Investing in Innovation (i3)is a pan-African initiative to support the commercialization and impact 60 promising early & growth-stage companies with grants & access to markets support. This program aims to help scale African health tech businesses that bring high-quality health products (medicines, consumables, medical devices, assistive technologies, etc.) closer to where patients are, at affordable prices.
Inspired by the progress and promise of African innovators in supply chain, the Bill & Melinda Gates Foundation, alongside Merck Sharp & Dohme (MSD), WHO AFRO, AUDA-NEPAD, and AmerisourceBergen, are launching i3.
Pillars of the program:
Access to Markets: i3’s flagship event that connects innovators to leading local and international industry players, financial institutions, donors, and governments to establish partnerships and pilot projects that fuel impact and scale.
Risk-Tolerant Finance: i3 provides systematic grants of $50,000 to all participating startups. This flexible funding is provided to address key business model needs and advance the startups’ charitable impacts.
Investment readiness support: i3 provides participating startups with tailored investment readiness support, delivered by leading innovation experts at CCHUB, Startupbootcamp Afritech, IMPACT Lab and Villgro Africa.
The application deadline for North, West and East African applications was on the 14thof August. If you apply after this date, your applications will not be reviewed.
Applications from Southern Africa will be accepted until the 21st of August at 11:59 pm WAT.